Status of surgical trials in clinical oncology, part 1;Stand der chirurgischen Studien in der Onkologie, Teil 1

Chirurg

Volumn 71, Issue 6, 2000, Pages 646-657

  Zacherl, J ^a   Jakesz, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Esophageal cancer; Gastric cancer; Surgical trials

Indexed keywords

ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; GASTRECTOMY; HUMAN; LYMPHADENECTOMY; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESEARCH; REVIEW; SPLENECTOMY; STOMACH TUMOR; TIME;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RESEARCH; SPLENECTOMY; STOMACH NEOPLASMS; TIME FACTORS;

EID: 0034199175     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040051116     Document Type: Article

References (81)

1. Anderson LL, Lad TE (1982) Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer 50: 1587
2. Araújo CMM, Souhami L, Gil RA, Carvalho R, et al (1991) A randomized trial comparing radiation therapy alone versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67: 2258
3. Arnott SJ, Duncan W, Kerr GR, Walbaum PR, et al (1992) Low dose preoperative radiotherapy for carcinoma of the esophagus: results of a randomised clinical trial. Radiother Oncol 24: 108
4. Bonenkamp JJ, Songung I, Hermans J, Sasako M, et al (1995) Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345: 745
5. Bonenkamp JJ, Hermans J, Sasako M, van den Velde CJH, Dutch Gastric Cancer Group (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340: 908
6. Bosset JF, Gignoux M, Triboulet JP, Tiret E, et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337: 161
7. Bozzetti F, Marubini E, Bonfanti G, Miceli R, et al (1997) Total versus ubtotal gastrectomy. Surgical morbidity and mortality rates in a multicenter randomized trial. Ann Surg 226: 613
8. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L, Italian Gastrointestinal Tumor Study Group (1999) Subtotal versus total gastrectomy for gastric cancer. Ann Surg 230: 170
9. Böttcher K, Siewert JR, Roder JD, Busch R, et al (1994) Risiko der chirurgischen Therapie des Magencarcinoms in Deutschland. Ergebnisse der Deutschen Magencarcinom-Studie 1992. Chirurg 65: 298
10. Brady MS, Rogatko A, Dent L, Shiu MH (1991) Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 126: 359
11. Chu KM, Law SYK, Fok M, Wong J (1997) A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 174: 320
12. Cushieri A, Fayers P, Fielding J, Craven J, et al (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 347: 995
13. Cushieri A, Weeden S, Fielding J, Bancewicz J, et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 79: 1522
14. Dent DM, Madden MV, Price SK (1988) Randomized comparison of R1 and R2 gastrectomy for gastric cancer. Br J Surg 75: 110
15. Fass J, Jansen M, Zengel K, Reinecke T, et al (1998) Results of intraperitoneal active charcoal-mitomycin C therapy of stomach carcinoma with serosa invasion. Langenbecks Arch Chir Suppl Kongressbd 115: 1363
16. Fink U, Stein HJ, Bochtler J, Roder JD, et al (1994) Neoadjuvant therapy for squamous cell esophageal cancer. Ann Oncol 5 [Suppl 3]: 17
17. Fink U, Stein HJ, Siewert JR (1998) Multimodale Therapie die Tumoren des oberen Gastrointestinaltrakts. Chirurg 69: 349
18. Fok M, McShane J, Law SY, Wong J (1994) A prospective randomized study on radiotherapy and surgery in the treatment of esophageal carcinoma. Asian J Surg 17: 223
19. Fujimura T, Yonemura Y, Muraoka K, Takamura H, et al (1994) Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg 18: 150
20. Gignoux M, Roussel A, Paillot B, Gillet M, et al (1987) The value of preoperative radiotherapy in esophageal cancer: results of a study of the EORTC. World J Surg 11: 426
21. Girling DJ, Clark PI (1992) Randomized trials in the treatment of cancer of the esophagus. J Clin Oncol 10: 1031
22. Goldmine M, Maddem G, LePrise E, Meunier B, et al (1993) Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg 80: 367
23. Gouzi JL, Huguier M, Fagniez PL, Launois B, et al (1989) Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A french prospective controlled study. Ann Surg 209: 162
24. Griffith JP, Sue-Ling HM, Martin I, Dixon MF, et al (1995) Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 36: 684
25. Hagiwara A, Takahashi T, Kojima O, Sawai K, et al (1992) Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 339: 629
26. Hamazoe R, Maeta M, Kaibara N (1994) Intraperitoneal thermo-chemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomised controlled study. Cancer 73: 2048
27. Herfarth Ch (1999) Onkologische Chirurgie: Spätergebnisse eine zwingende Alltagsverpflichtung. Chirurg 70: 1041
28. Herskovic A, Martz K, Al-Sarraf M, Leichman L (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593
29. Hirose K, Katayama K, Iida A, Yamaguchi A, et al (1999) Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: Evaluation by multivariate regression analysis. Oncology 57: 106
30. Huang GJ, Gu XZ, Wang LJ, Zhang ZX, et al. (1990) Combined preoperative irradiation and surgery versus surgery alone for squamous cell carcinoma of the midthoracic esophagus: a prospective randomized study in 360 patients. In: Ferguson MK, Little AG, Skinner DB (eds) Diseases of the esophagus. Malignant diseases. Future, New York, p 275
31. Itzbicki JR, Hosch SB, Pichlmeier U, Rehders A, et al (1997) Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 337: 1188
32. Jacobi CA, Zieren HU, Müller JM, Pichlmaier H (1996) Systematische Lymphadenektomie beim Ösophaguskarzinom - vorläufige Ergebnisse einer prospektiv randomisierten Studie. Zentralbl Chir 121: 110
33. Kang YK, Choi DW, Im YH, Kim CM, et al (1996) A phase II randomized comparison of neoadjuvant chemotherapy followed by surgery for locally advanced stomach cancer. Proc Am Soc Clin Oncol 15: 215
34. Kato H, Watanabe H, Tachimori Y, Izuka T (1991) Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 51: 931
35. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, et al (1998) Chemotherapy followed by surgery compared with surgery alone for localised esophageal cancer. N Engl J Med 339: 1979
36. Kestle JRW (1999) Clinical trials. World J Surg 23: 1205
37. Kitamura K, Nishida S, Ichikawa D, Taniguchi H, et al (1999) No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer. Br J Surg 86: 119
38. Kok TC, Lanschot J v, Siersema PD, Overhagen H v, Tilanus HW (1997) Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase II multicenter randomized controlled trial. Proc ASCO 16: 277
39. Kwon SJ, Korean Gastric Cancer Study Group (1997) Prognostic impact of splenectomy on gastric cancer: results of the Korean Gastric Cancer Study Group. World J Surg 21: 837
40. Launois B, Delarue D, Campion JP, Kerbaol M (1981) Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153: 690
41. Law S, Fok M, Chow S, Chu KM, Wong J (1997) Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114: 210
42. Law SY, Wong J (1997) Esophageal cancer surgery: the value of controlled clinical trials. Semin Surg Oncol 13: 281
43. 42a. LePrise E, Etienne PL, Meunier B, Maddern G, et al (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73: 1779
44. Lisborg P, Jatzko G, Horn M, Neumann HJ, et al (1994) Radical surgery (R2 resection) for gastric cancer. A multivariate analysis. Scand J Gastroenterol 29: 1024
45. Lygidakis NJ, Sgourakis G, Aphinives P (1999) Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial. Hepatogastroenterology 46: 2035
46. McLeod RS (1999) Issues in surgical randomized controlled trials. World J Surg 23: 1210
47. Maehara Y, Moriguchi S, Yoshida M, Takahashi I, et al (1991) Splenectomy does not correlated with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Cancer 67: 3006
48. Natsugoe S, Mueller J, Stein HJ, Feith M, et al (1998) Micrometastasis and tumor cell microinvolvement of lymph nodes in esophageal squamous cell cancer. Cancer 83: 858
49. Newaishy GA, Read GA, Duncan W, Kerr GR (1982) Results of radical radiotherapy of squamous cell carcinoma of the esophagus. Clin Radiol 33: 347
50. Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175: 47
51. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, et al (1992) Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16: 1104
52. O'Sullivan GC, Sheehan D, Clarke A, Stuart R, et al (1999) Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 116: 543
53. Otsuji E, Yamaguchi T, Sawai K, Ohara M, Takahashi T (1996) End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinoma. Surgery 120: 40
54. Peracchia A, Fumagalli U, Segalin A, Bonavina L (1995) Pathogenesis, diagnosis and treatment of cancer of the tubular esophagus. Dis Esophagus 8: 167
55. Recht A (1995) The role of radiation therapy in treating patients with potentially resectable carcinoma of the esophagus. Chest 107: 233 S
56. Rich TA, Skibber JM, Ajani JA, Buchholz DJ, et al (1995) Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 32: 1025
57. Robertson CS, Chung SCS, Woods SDS, Griffin SM (1994) A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 220: 176
58. Rosen HR, Jatzko G, Repse S, Potrc S, et al (1998) Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian working group for surgical oncology. J Clin Oncol 16: 2733
59. Roth JA, Pass HI, Flanagan MM, Graeber GM, et al (1988) Randomized clinical of preoperative and postoperative chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96: 242
60. Sasako M, Dutch Gastric Cancer Study Group (1997) Risk factors for surgical treatment in the Dutch gastric cancer trial. Br J Surg 84: 1567
61. Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R (1994) Adjuvant intraperitoneal cisplatin chemotherapy does not improve longterm survival after surgery for advanced gastric cancer. J Clin Oncol 12: 970
62. Schlag P für die Chirurgische Arbeitsgemeinschaft für Onkologie der Deutschen Gesellschaft für Chirurgie Studiengruppe (1992) Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 127: 1146
63. Siewert JR, Böttcher K, Roder JD, Busch R, et al (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80: 1015
64. Siewert JR, Schuhmacher C, Fink U (1998) The German EORTC study of neoadjuvant therapy of stomach carcinoma. Langenbecks Arch Chir Suppl Kongressbd 115: 717
65. Siewert JR, Stein HJ (1999) Lymph-node dissection in squamous cell esophageal cancer - who benefits? Langenbecks Arch Surg 384: 141
66. Siewert JR, Stein HJ (1997) Barrett's cancer: indications, extent, and results of surgical resection. Semin Surg Oncol 13: 245
67. Solomon MJ, Laxamaa A, Devore L, McLeod RS (1994) Randomized controlled trials in surgery. Surgery 115: 707
68. Songun I, Keizer HJ, Hermans J, Klementschitsch P, et al (1999) Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. Eur J Cancer 35: 558
69. Teniere P, Hay JM, Fingerhut A, Fagniez PL (1997) Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 173: 123
70. Toge T, Seto Y, Yanagawa E, Hattori T (1989) Effect of slenectomy on the prognosis in gastric cancer patients. Gastroenterol Surg 9: 1887
71. Urba S, Orringer M, Turrisi A, Whyte R, et al (1997) A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer: updated analysis. Proc ASC0 16: 277
72. Viste A, Svanes K, Janssen CW, Maartmann-Moe H, Soreide O (1994) Prognostic importance of radical lymphadenectomy in curative resections for gastric cancer. Eur J Surg 160: 497
73. Walsh TN, Noonan N, Hollywood D, Kelly A, et al (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462
74. a. Walsh TN, Noonan N, Hollywood D, Kelly A, et al (1996) Multimodality treatment plus surgery versus surgery alone for oesophageal squamous cell carcinoma. In: Peracchia A (ed) Recent advances in diseases of the esophagus. Monduzzi Editory, Bologna, p 451
75. Wanebo HJ, Kennedy BJ, Winchester DP, Stewart AK, Fremgen AM (1997) Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J Am Coll Surg 185: 177
76. Wang M, Gu XZ, Yin WB, Huang GJ, et al (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16: 325
77. Whipple AO, Parsons WB, Mullins CR (1935) Treatment of carcinoma of the ampulla of Vater. Ann Surg 102: 763
78. a. Yonemura Y, Sawa T, Kinoshita K, Matsuki N, et al (1993) Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 17: 256
79. Yu W, Whang I, Suh I, Averbach A, et al (1998) Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 228: 347
80. Zacherl J, Scheuba C, Jakesz R, Wenzl E (1999) Ratinale of preserving the spleen in gastric cancer surgery. Acta Chir Austr 31 [Suppl 155]: 23
81. Zhang ZX, Gu XZ, Yin WB, Huang GJ, et al (1998) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric (AGC) - report on 370 patients. Int J Radiation Oncology Biol Phys 42: 929